Age (years) | | | | |
19–49 | 0.47 (0.22 to 1.02) | 0.51 (0.22 to 1.18) | 0.58 (0.31 to 1.05) | 0.51 (0.22 to 1.18) |
50–69 | 0.82 (0.63 to 1.06) | 0.89 (0.66 to 1.19) | 0.65 (0.52 to 0.82) | 0.67 (0.51 to 0.89) |
⩾70 | 0.91 (0.62 to 1.34) | 0.91 (0.54 to 1.54) | 0.88 (0.63 to 1.23) | 0.82 (0.49 to 1.35) |
Sex | | | | |
Men | 0.94 (0.74 to 1.18) | 0.88 (0.67 to 1.15) | 0.92 (0.75 to 1.13) | 0.70 (0.54 to 0.90) |
Women | 0.84 (0.56 to 1.26) | 0.74 (0.45 to 1.21) | 0.99 (0.71 to 1.39) | 0.69 (0.44 to 1.08) |
Indication | | | | |
Acute | 0.90 (0.50 to 1.62) | 0.81 (0.45 to 1.46) | 0.94 (0.55 to 1.62) | 0.73 (0.42 to 1.26) |
Elective | 0.84 (0.67 to 1.05) | 0.85 (0.65 to 1.11) | 0.72 (0.59 to 0.89) | 0.66 (0.51 to 0.86) |
Angiographic status | | | | |
No significant stenoses | 0.89 (0.42 to 1.89) | 0.72 (0.34 to 1.54) | 1.16 (0.62 to 2.15) | 0.69 (0.36 to 1.34) |
1 or 2 VD | 1.20 (0.78 to 1.83) | 0.94 (0.61 to 1.45) | 1.53 (1.04 to 2.24) | 0.87 (0.58 to 1.31) |
3 VD or PLM stenosis | 1.25 (0.93 to 1.69) | 0.84 (0.62 to 1.15) | 1.21 (0.92 to 1.54) | 0.63 (0.46 to 0.83) |
Charlson co-morbidity index | | | | |
0 | 0.66 (0.42 to 1.03) | 0.72 (0.43 to 1.20) | 0.61 (0.42 to 0.89) | 0.61 (0.38 to 0.99) |
1–2 | 0.97 (0.74 to 1.28) | 0.92 (0.67 to 1.27) | 0.95 (0.75 to 1.20) | 0.70 (0.51 to 0.96) |
>2 | 0.83 (0.54 to 1.27) | 0.74 (0.45 to 1.20) | 0.86 (0.60 to 1.24) | 0.68 (0.43 to 1.07) |
Revascularisation at baseline or within one year of follow up |
Yes | 0.98 (0.72 to 1.32) | 0.85 (0.60 to 1.20) | 0.90 (0.70 to 1.18) | 0.61 (0.44 to 0.84) |
No | 0.79 (0.60 to 1.05) | 0.88 (0.63 to 1.24) | 0.92 (0.73 to 1.16) | 0.87 (0.64 to 1.19) |